Holen Sie sich die Stockscreener-App
6.71
2.42%
-0.16
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Verastem Stock Skyrockets 121% in 3 Months: Here Is Why - Zacks Investment Research
Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock - simplywall.st
Precigen (PGEN) Director Jeffrey Kindler Sells 185,000 Shares - GuruFocus
Precigen director Jeffrey Kindler sells $1.38m in stock By Investing.com - Investing.com Australia
Precigen (PGEN) director sells 185K shares in one day - Stock Titan
Does Reliance On Papzimeos Skew Precigen’s (PGEN) Risk Profile Or Validate Its Focused Strategy? - Yahoo Finance
Is Precigen (PGEN) Undervalued After Reaching Quarterly Profitability? - Sahm
Precigen Director Sold Shares Worth Over $1.3M - TradingView
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Eastern Progress
Precigen (PGEN) director plans 185,000-share 2026 sale - Stock Titan
Precigen COO Rutul Shah sells $375,000 in shares By Investing.com - Investing.com South Africa
Precigen CCO Phil Tennant sells $593,745 in stock By Investing.com - Investing.com Nigeria
Precigen Insider Sold Shares Worth $375,000, According to a Recent SEC Filing - marketscreener.com
Precigen (PGEN) insider lines up another stock sale after four recent trades - Stock Titan
Precigen (NASDAQ: PGEN) officer to sell 79,166 shares in 2026 - Stock Titan
Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers - Investing News Network
3 Growth Companies With High Insider Ownership And 55% Earnings Growth - Sahm
Precigen (PGEN) officer targets $259,935 insider stock sale - Stock Titan
Precigen (NASDAQ:PGEN) Trading Down 3.6%Here's Why - MarketBeat
$Precigen (PGEN.US)$ keep it up! - Moomoo
Precigen (NASDAQ:PGEN) Hits New 12-Month HighTime to Buy? - MarketBeat
Precigen stock hits 52-week high at 7.33 USD By Investing.com - Investing.com Australia
Reasons Why Investors Should Consider Betting on PGEN Stock - TradingView
Precigen stock hits 52-week high at 7.33 USD - Investing.com
Precigen (PGEN) Stock: Ends Up by 6.30% at $7.17 in the Latest Session; Key Range: Support at $6.81 and Resistance at $7.53 Frame the Range under the Current SnapshotPut Spread Alert - vinanet.vn
Stock Traders Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Alpine Woods Capital Investors LLC Takes $1.31 Million Position in Precigen, Inc. $PGEN - MarketBeat
$Precigen (PGEN.US)$ DCA'd Up. Ready for the next leg higher - Moomoo
Precigen (PGEN) Price and Levels: Finishes 3.05% Higher at $6.75 in the Latest Session; $6.41 and $7.09 Define the Nearby Reference Levels at the CloseCounter Trend Trade - vinanet.vn
Precigen Inc. (PGEN) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Precigen (NASDAQ:PGEN) Stock Price Up 5.5%Time to Buy? - MarketBeat
Precigen Inc (PGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precigen (NASDAQ:PGEN) Trading Down 5.5%What's Next? - MarketBeat
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice - Yahoo Finance
Precigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? - Yahoo Finance
US High Growth Tech Stocks To Watch: 3 Top Picks - simplywall.st
Precigen (PGEN) Q2 2026 Earnings Call Transcript - AOL.com
Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage - webull.com
Precigen (PGEN) Insider Rutul Shah Sells 32,739 Shares - GuruFocus
Precigen jumps 266% on FDA approval but faces h... - Pluang
Precigen: Has To Grow Into Its Valuation - Seeking Alpha
Wall Street Zen Upgrades Precigen (NASDAQ:PGEN) to "Strong-Buy" - MarketBeat
Precigen (NASDAQ:PGEN) COO Sells $224,589.54 in Stock - MarketBeat
COO sale: Precigen (PGEN) insider trades 32,739 shares via plan - Stock Titan
Merck affiliates disclose 4.9% Precigen (NASDAQ: PGEN) ownership - Stock Titan
HC Wainwright Has Positive Outlook for Precigen Q3 Earnings - MarketBeat
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Zacks Research - MarketBeat
Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential With An 80% Upside - DirectorsTalk Interviews
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement (PGEN) - Seeking Alpha
PRECIGEN, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $18 FROM $14 - webull.com
Precigen (NASDAQ: PGEN) Form 144 covers 32,739 common shares for sale - Stock Titan
HC Wainwright Predicts Precigen's Q4 Earnings (NASDAQ:PGEN) - MarketBeat
Results: Precigen, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - 富途牛牛
Precigen (NASDAQ:PGEN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Arrowstreet Capital Limited Partnership Acquires Shares of 395,695 Precigen, Inc. $PGEN - MarketBeat
Precigen, Inc. (PGEN) Interactive Stock Chart - Yahoo! Finance Canada
Germantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval - The Business Journals
Precigen (NASDAQ:PGEN) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Precigen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):